Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Abstract The immune-cell origin of hematologic malignancies provides a unique avenue for the understanding of both the mechanisms of immune responsiveness and immune escape, which has accelerated the progress of immunotherapy. Several categories of immunotherapies have been developed and are being f...
Main Authors: | Lu Tang, Zhongpei Huang, Heng Mei, Yu Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-08-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-023-01521-5 |
Similar Items
-
Therapeutic Advances in Immunotherapies for Hematological Malignancies
by: Ayako Nogami, et al.
Published: (2022-09-01) -
Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023-10-01) -
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2020-08-01) -
COVID-19 in Hematologic Malignancies: Big Challenges
by: Yongxian Hu, et al.
Published: (2020-10-01) -
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
by: Ji-Yoon Noh, et al.
Published: (2020-10-01)